Article Details

A well-funded cancer drug startup brings on GSK's Axel Hoos as CEO

Retrieved on: 2021-07-07 20:26:15

Tags for this article:

Click the tags to see associated articles and topics

A well-funded cancer drug startup brings on GSK's Axel Hoos as CEO. View article details on hiswai:

Excerpt

The company launched last October with $108 million in Series A funding from Atlas Venture, Omega Funds, Vida Ventures and others. A little more ...

Article found on: www.biopharmadive.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up